Disc Medicine (IRON) Amortization of Deferred Charges (2024 - 2026)
Disc Medicine's (IRON) quarterly Amortization of Deferred Charges came in at $206000.0 in Q1 2026, little changed year-on-year from $207000.0 in Q1 2025, and down 2.37% on a QoQ basis from $211000.0 in Q4 2025.
Disc Medicine (IRON) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Disc Medicine (IRON) has 3 years of Amortization of Deferred Charges data on file, last reported at $206000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges changed 0.48% year-over-year to $206000.0 in Q1 2026; TTM through Mar 2026 was $836000.0, a 150.3% increase from a year earlier, with the FY2025 full-year figure at $837000.0, up 559.06% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $206000.0, down from $211000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for IRON reached as high as $211000.0 in Q3 2025 and fell as low as $127000.0 in Q4 2024.
- Historically, Amortization of Deferred Charges has averaged $195000.0 across 3 years, with a median of $207500.0 in 2025.
- Across the five-year window, Amortization of Deferred Charges soared 66.14% in 2025 and dropped 0.48% in 2026, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $127000.0 in 2024, then soared by 66.14% to $211000.0 in 2025, then decreased by 2.37% to $206000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $206000.0 in Q1 2026, $211000.0 in Q4 2025, and $211000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.88 Bn | 2.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 211,000.00 |
| Dec 31, 2025 | 211,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 207,000.00 |
| Mar 31, 2025 | 207,000.00 |
| Dec 31, 2024 | 127,000.00 |
| Dec 31, 2024 | 127,000.00 |